GlaxoSmithKline to commercialise Cann Group cannabis medication

Medicinal cannabis producer Cann Group and global pharmaceutical firm GlaxoSmithKline are progressing negotiations relating to the commercialisation of Cann’s Satipharm CBD capsules. Cann Group, which operates a major cannabis growing and processing centre at Mildura, Victoria (pictured) announced it was in negotiation with GlaxoSmithKline’s Australian arm Haleon. The negotiations involve an exclusive agreement covering distribution…

DroneShield’s DroneCannon features in Agile Shield

Drone detection and countermeasure company DroneShield has announced that one of its key products has been integrated into defence prime contractor Lockheed Martin Australia’s Agile Shield battlefield management programme. The incorporation of the company’s DroneCannon Mk2 wide area non-kinetic effector (pictured) was announced as part of a collaboration with LMA’s Science, Technology, Engineering, Leadership and…

There’s a buzz about ‘sustainable’ fuels – but they cannot solve aviation’s colossal climate woes

By Susanne Becken, Griffith University; Brendan Mackey, Griffith University, and David Simon Lee, Manchester Metropolitan University The global airline industry is fast recovering from the unprecedented pause to flying imposed by COVID-19. In some parts of the world, such as the Middle East, airlines are even expanding rapidly – well beyond pre-pandemic levels. But how…

Mildura cannabis facility receives manufacturing licence

Medicinal cannabis grower and manufacturer Cann Group has been granted a manufacturing and GMP testing licence for its Mildura, Victoria production facility (main picture, and below) by the Therapeutic Goods Administration (TGA). The Mildura GMP Licence enables Cann to manufacture Active Pharmaceutical Ingredients (API), hard capsules, Satipharm capsules for human therapeutic use, and perform in-house…

Avecho cannabis product effective for arthritis

Drug delivery company Avecho has announced positive results from its Phase 2a studying its topical cannabinoid gel for the management of pain associated with osteoarthritis of the hand. The study dosed patients over a four-week period, with the study demonstrating statistically significant daily improvements in hand pain, hand functionality, grip strength, finger stiffness and anxiety.…